Bioxcel Therapeutics Inc (BTAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 17,180 | 28,757 | 37,320 | 18,575 | 31,013 |
| Receivables | 216 | 233 | N/A | 17 | N/A |
| Inventories | 500 | 722 | 459 | 506 | 642 |
| Other current assets | 12,067 | 10,945 | 934 | 995 | 1,385 |
| TOTAL | $33,908 | $44,685 | $44,403 | $25,243 | $37,777 |
| Non-Current Assets | |||||
| PPE Net | 117 | 175 | 249 | 324 | 399 |
| Other Non-Current Assets | 0 | 56 | 140 | 222 | 390 |
| TOTAL | $117 | $231 | $389 | $546 | $789 |
| Total Assets | $34,025 | $44,916 | $44,792 | $25,789 | $38,566 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 22,431 | 24,931 | 16,823 | 11,216 | 5,608 |
| Accounts payable and accrued liabilities | 16,425 | 14,839 | 16,398 | 16,814 | 15,569 |
| Accrued Expenses | 6,388 | 4,341 | 4,363 | 5,090 | 3,986 |
| Other current liabilities | 9,750 | 9,815 | 220 | 256 | 383 |
| TOTAL | $54,994 | $53,926 | $37,804 | $33,376 | $25,546 |
| Non-Current Liabilities | |||||
| Long Term Debt | 77,858 | 84,663 | 92,302 | 97,469 | 99,918 |
| Other Non-Current Liabilities | 6,716 | 1,790 | 3,605 | 2,611 | 3,274 |
| TOTAL | $84,574 | $86,453 | $95,907 | $100,080 | $103,192 |
| Total Liabilities | $139,568 | $140,379 | $133,711 | $133,456 | $128,738 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 30,878 | 27,075 | 21,869 | 14,557 | 6,056 |
| Common Shares | 27 | 76 | 73 | 60 | 59 |
| Retained earnings | -732,785 | -720,094 | -707,549 | -676,638 | -657,451 |
| TOTAL | $-105,543 | $-95,463 | $-88,919 | $-107,667 | $-90,172 |
| Total Liabilities And Equity | $34,025 | $44,916 | $44,792 | $25,789 | $38,566 |